| Dr Karthik Sabapathy, DO | |
|
1110 E State Highway 114 Ste 100, Southlake, TX 76092-5251 | |
| (817) 502-7411 | |
| (817) 502-7412 |
| Full Name | Dr Karthik Sabapathy |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 8 Years |
| Location | 1110 E State Highway 114 Ste 100, Southlake, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124482740 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Axis Brain And Back Institute Pllc | 0042432015 | 5 |
News Archive
Optivus Proton Therapy has announced that Belgium-based IBA has agreed to pay $1.25 million to settle a lawsuit alleging IBA infringed on three Optivus proton therapy patents.
Aetna is offering fully insured health plan customers, including Medicare members, in Ohio's Wood, Ottawa and Fulton counties an extra two months to make premium payments and file claims, among other assistance. People in those counties were affected by tornados and severe weather in early June.
A team of researchers at the University of Colorado School of Medicine and the VA Eastern Colorado Health Care System recently surveyed patients to understand barriers to reducing the use of opioids to manage chronic pain. The results of those interviews are published in the current issue of the journal Pain Medicine.
An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.
› Verified 5 days ago
| Entity Name | Axis Brain And Back Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689085193 PECOS PAC ID: 0042432015 Enrollment ID: O20141106000405 |
News Archive
Optivus Proton Therapy has announced that Belgium-based IBA has agreed to pay $1.25 million to settle a lawsuit alleging IBA infringed on three Optivus proton therapy patents.
Aetna is offering fully insured health plan customers, including Medicare members, in Ohio's Wood, Ottawa and Fulton counties an extra two months to make premium payments and file claims, among other assistance. People in those counties were affected by tornados and severe weather in early June.
A team of researchers at the University of Colorado School of Medicine and the VA Eastern Colorado Health Care System recently surveyed patients to understand barriers to reducing the use of opioids to manage chronic pain. The results of those interviews are published in the current issue of the journal Pain Medicine.
An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karthik Sabapathy, DO 1110 E State Highway 114 Ste 100, Southlake, TX 76092-5251 Ph: (817) 502-7411 | Dr Karthik Sabapathy, DO 1110 E State Highway 114 Ste 100, Southlake, TX 76092-5251 Ph: (817) 502-7411 |
News Archive
Optivus Proton Therapy has announced that Belgium-based IBA has agreed to pay $1.25 million to settle a lawsuit alleging IBA infringed on three Optivus proton therapy patents.
Aetna is offering fully insured health plan customers, including Medicare members, in Ohio's Wood, Ottawa and Fulton counties an extra two months to make premium payments and file claims, among other assistance. People in those counties were affected by tornados and severe weather in early June.
A team of researchers at the University of Colorado School of Medicine and the VA Eastern Colorado Health Care System recently surveyed patients to understand barriers to reducing the use of opioids to manage chronic pain. The results of those interviews are published in the current issue of the journal Pain Medicine.
An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.
› Verified 5 days ago